Skip to main content
Erschienen in: Journal of Inherited Metabolic Disease 6/2013

01.11.2013 | Original Article

Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery

verfasst von: Christina Lampe, Christian Lampe, Manfred Schwarz, Wibke Müller-Forell, Paul Harmatz, Eugen Mengel

Erschienen in: Journal of Inherited Metabolic Disease | Ausgabe 6/2013

Einloggen, um Zugang zu erhalten

Abstract

Objective

To analyse diagnostic value of somato-sensory evoked potentials (SEP), magnetic resonance imaging (MRI), and clinical neurological examination in the decision for decompression surgery in mucopolysaccharidosis (MPS) VI patients with craniocervical cord compression (CCJ).

Methods

We retrospectively analysed neurological examination, SEP of the median nerve and MRI outcomes from 31 MPS VI patients. Individual scores for each test (based on severity of findings) and a sum of scores of all three procedures (CCJ score) were evaluated for their potential to measure the need for and improvement after surgery. Differences between rapidly and slowly progressive patients were also evaluated.

Results

Fourteen patients (45 %) aged 4–34 years underwent decompression surgery. Median age at first operation was lower in rapidly than in slowly progressive patients (12 vs. 24 years; P = 0.008). Neurological and SEP findings but not MRI results differed significantly between non-operated and operated patients (P < 0.001, P = 0.003 and P = 0.08, respectively). A significant relationship was found between MRI and clinical neurological examination (P < 0.001) and between SEP and clinical neurological examination (P = 0.01) but not between MRI and SEP (P = 0.06). The CCJ score discriminated between operated and non-operated patients (4–9 points vs. 0–3 points; P < 0.001) and decreased in 61.5 % of patients after surgery.

Conclusions

CCJ is common in rapidly and slowly progressive MPS VI patients. The CCJ score is an objective and transparent tool for assessing pathology of the CCJ, the need for surgery, and improvement after surgery.
Literatur
Zurück zum Zitat Boor R, Goebel B, Taylor MJ (1998) Subcortical somatosensory evoked potentials after median nerve stimulation in children. Eur J Paediatr Neurol 2:137–143PubMedCrossRef Boor R, Goebel B, Taylor MJ (1998) Subcortical somatosensory evoked potentials after median nerve stimulation in children. Eur J Paediatr Neurol 2:137–143PubMedCrossRef
Zurück zum Zitat Boor R, Miebach E, Brühl K, Beck M (2000) Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 31:122–127PubMedCrossRef Boor R, Miebach E, Brühl K, Beck M (2000) Abnormal somatosensory evoked potentials indicate compressive cervical myelopathy in mucopolysaccharidoses. Neuropediatrics 31:122–127PubMedCrossRef
Zurück zum Zitat Gallegos-Arreola MP, Machorro-Lazo MV, Flores-Martínez SE et al (2000) Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses. Arch Med Res 31:505–510PubMedCrossRef Gallegos-Arreola MP, Machorro-Lazo MV, Flores-Martínez SE et al (2000) Urinary glycosaminoglycan excretion in healthy subjects and in patients with mucopolysaccharidoses. Arch Med Res 31:505–510PubMedCrossRef
Zurück zum Zitat Giugliani R, Harmatz P, Wraith JE (2007) Management guidelines for mucopolysaccharidosis VI. Pediatrics 120:405–418PubMedCrossRef Giugliani R, Harmatz P, Wraith JE (2007) Management guidelines for mucopolysaccharidosis VI. Pediatrics 120:405–418PubMedCrossRef
Zurück zum Zitat Kachur E, Del Maestro R (2000) Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 47:223–228PubMed Kachur E, Del Maestro R (2000) Mucopolysaccharidoses and spinal cord compression: case report and review of the literature with implications of bone marrow transplantation. Neurosurgery 47:223–228PubMed
Zurück zum Zitat Lachman R, Martin KW, Castro S, Basto MA, Adams A, Teles EL (2010) Radiologic and neuroradiologic findings in the mucopolysaccharidoses. J Pediatr Rehabil Med 3:109–118PubMed Lachman R, Martin KW, Castro S, Basto MA, Adams A, Teles EL (2010) Radiologic and neuroradiologic findings in the mucopolysaccharidoses. J Pediatr Rehabil Med 3:109–118PubMed
Zurück zum Zitat Mut M, Cila A, Varli K, Akalan N (2005) Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 107:230–235PubMedCrossRef Mut M, Cila A, Varli K, Akalan N (2005) Multilevel myelopathy in Maroteaux-Lamy syndrome and review of the literature. Clin Neurol Neurosurg 107:230–235PubMedCrossRef
Zurück zum Zitat Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452 Neufeld EF, Muenzer J (2001) The mucopolysaccharidoses. In: Scriver CR, Beaudet AL, Sly WS, Valle D (eds) The metabolic and molecular bases of inherited disease. McGraw-Hill, New York, pp 3421–3452
Zurück zum Zitat Penning L, Wilmink JT, van Woerden HH, Knol E (1986) CT myelographic findings in degenerative disorders of the cervical spine: clinical significance. AJR Am J Roentgenol 146:793–801PubMedCrossRef Penning L, Wilmink JT, van Woerden HH, Knol E (1986) CT myelographic findings in degenerative disorders of the cervical spine: clinical significance. AJR Am J Roentgenol 146:793–801PubMedCrossRef
Zurück zum Zitat Ratliff J, Voorhies R (2000) Increased MRI signal intensity in association with myelopathy and cervical instability: case report and review of the literature. Surg Neurol 53:8–13PubMedCrossRef Ratliff J, Voorhies R (2000) Increased MRI signal intensity in association with myelopathy and cervical instability: case report and review of the literature. Surg Neurol 53:8–13PubMedCrossRef
Zurück zum Zitat Scarpa M, Buffone E, La Marca P, Campello M, Rampazzo A (2010) Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: a case series. J Pediatr Rehabil Med 3:71–75PubMed Scarpa M, Buffone E, La Marca P, Campello M, Rampazzo A (2010) Difficulties in diagnosing slowly progressive mucopolysaccharidosis VI: a case series. J Pediatr Rehabil Med 3:71–75PubMed
Zurück zum Zitat Stöhr M, Dichgans J, Buettner UW, Hess W (eds) (2005) Evozierte potentiale. 4. Aufl. Springer, Berlin Stöhr M, Dichgans J, Buettner UW, Hess W (eds) (2005) Evozierte potentiale. 4. Aufl. Springer, Berlin
Zurück zum Zitat Swiedler SJ, Beck M, Bajbouj M et al (2005) Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet 134A:144–150PubMedCrossRef Swiedler SJ, Beck M, Bajbouj M et al (2005) Threshold effect of urinary glycosaminoglycans and the walk test as indicators of disease progression in a survey of subjects with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome). Am J Med Genet 134A:144–150PubMedCrossRef
Zurück zum Zitat Tamaki N, Kojima N, Tanimoto M, Suyama T, Matsumoto S (1987) Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Neurosurgery 21:416–419PubMedCrossRef Tamaki N, Kojima N, Tanimoto M, Suyama T, Matsumoto S (1987) Myelopathy due to diffuse thickening of the cervical dura mater in Maroteaux-Lamy syndrome: report of a case. Neurosurgery 21:416–419PubMedCrossRef
Zurück zum Zitat Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA (2001) Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 48:849–853PubMed Thorne JA, Javadpour M, Hughes DG, Wraith E, Cowie RA (2001) Craniovertebral abnormalities in type VI mucopolysaccharidosis (Maroteaux-Lamy syndrome). Neurosurgery 48:849–853PubMed
Zurück zum Zitat Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:5PubMedCrossRef Valayannopoulos V, Nicely H, Harmatz P, Turbeville S (2010) Mucopolysaccharidosis VI. Orphanet J Rare Dis 5:5PubMedCrossRef
Zurück zum Zitat Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38PubMedCrossRef Vougioukas VI, Berlis A, Kopp MV, Korinthenberg R, Spreer J, van Velthoven V (2001) Neurosurgical interventions in children with Maroteaux-Lamy syndrome. Case report and review of the literature. Pediatr Neurosurg 35:35–38PubMedCrossRef
Zurück zum Zitat Young R, Kleinman G, Ojemann RG et al (1980) Compressive myelopathy in Maroteaux-Lamy syndrome: clinical and pathological findings. Ann Neurol 8:336–340PubMedCrossRef Young R, Kleinman G, Ojemann RG et al (1980) Compressive myelopathy in Maroteaux-Lamy syndrome: clinical and pathological findings. Ann Neurol 8:336–340PubMedCrossRef
Metadaten
Titel
Craniocervical decompression in patients with mucopolysaccharidosis VI: development of a scoring system to determine indication and outcome of surgery
verfasst von
Christina Lampe
Christian Lampe
Manfred Schwarz
Wibke Müller-Forell
Paul Harmatz
Eugen Mengel
Publikationsdatum
01.11.2013
Verlag
Springer Netherlands
Erschienen in
Journal of Inherited Metabolic Disease / Ausgabe 6/2013
Print ISSN: 0141-8955
Elektronische ISSN: 1573-2665
DOI
https://doi.org/10.1007/s10545-013-9591-5

Weitere Artikel der Ausgabe 6/2013

Journal of Inherited Metabolic Disease 6/2013 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.